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Abstract
Background: Previous work has suggested, but not demonstrated directly, a critical role for both glutamatergic and
GABAergic neurons of the pontine tegmentum in the regulation of rapid eye movement (REM) sleep.
Methodology/Principal Findings: To determine the in vivo roles of these fast-acting neurotransmitters in putative REM
pontine circuits, we injected an adeno-associated viral vector expressing Cre recombinase (AAV-Cre) into mice harboring
lox-P modified alleles of either the vesicular glutamate transporter 2 (VGLUT2) or vesicular GABA-glycine transporter (VGAT)
genes. Our results show that glutamatergic neurons of the sublaterodorsal nucleus (SLD) and glycinergic/GABAergic
interneurons of the spinal ventral horn contribute to REM atonia, whereas a separate population of glutamatergic neurons
in the caudal laterodorsal tegmental nucleus (cLDT) and SLD are important for REM sleep generation. Our results further
suggest that presynaptic GABA release in the cLDT-SLD, ventrolateral periaqueductal gray matter (vlPAG) and lateral
pontine tegmentum (LPT) are not critically involved in REM sleep control.
Conclusions/Significance: These findings reveal the critical and divergent in vivo role of pontine glutamate and spinal cord
GABA/glycine in the regulation of REM sleep and atonia and suggest a possible etiological basis for REM sleep behavior
disorder (RBD).
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Introduction
Rapid eye movement (REM) sleep is a distinct behavioral state
characterized by an activated cortical and hippocampal electro-
encephalogram and concurrent muscle atonia. Jouvet and
colleagues [1] were the first to identify the pontomedullary
junction as a region critically involved in the generation of REM
sleep. Later work by Siegel and colleagues showed that the REM-
sleep generating neurons were located in a restricted region of the
pons [2]. Over the last two decades, research by many, but in
particular, Sakai and colleagues [3] has revealed a ‘‘REM–on’’ cell
population in the peri-locus coeruleus (peri-LC) alpha in the cat.
Boissard and colleagues [4] have recently identified the homolo-
gous structure of the cat peri-LC alpha in rats and named this
region the sublaterodorsal tegmental nucleus (SLD) as it is located
just ventral to the caudal laterodorsal tegmental nucleus (cLDT)
and rostral to the LC. Unlike the cat peri-LC-alpha, however, the
rat SLD does not contain cholinergic or monoaminergic neurons.
Cell-body specific lesions that are restricted to the SLD produced
REM without atonia in the rat [5], a phenotype that is similar in
appearance to human REM sleep behavior disorder (RBD).
Combined cell-body specific lesions of the SLD and cLDT in the
rat reduced REM sleep by ca. 60% and, also, produced
fragmentation of the REM sleep state [5].
With respect to ‘‘REM-off’’ (inhibitory) neurons, we have
previously demonstrated that the ventrolateral periaqueductal gray
matter (vlPAG) and lateral pontine tegmentum (LPT) contain a
population of GABAergic neurons that project to and inhibit the
SLD [5,6]. Consistent with their putative ‘‘REM-off’’ role,
injection of the GABA agonist muscimol into the vlPAG-LPT
triggers large amounts of REM sleep in rats [7,8], cats [9] and
guinea pigs [10] while pretreatment with bicuculline blocks the
REM-inducing effects of muscimol in guinea pigs [10]. Cell-body
specific lesions of the vlPAG-LPT doubled total REM sleep time
and increased the number and duration of bouts of REM sleep
[5,11].
We hypothesized that mutually inhibitory REM-off and REM-
on areas in the mesopontine tegmentum may form the substrate of
the ‘‘switching circuitry’’ for REM sleep. In this putative switching
arrangement, GABAergic REM-on neurons of the SLD inhibit
GABAergic REM-off neurons of the vlPAG-LPT and vice versa.W e
further hypothesized that descending glutamatergic SLD neurons
and glycinergic/GABAergic premotor neurons of the spinal
ventral horn play a role in REM atonia. Because, however,
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spinal ventral horn, it has been difficult to characterize the
respective in vivo roles of these fast neurotransmitters in regulating
REM sleep phenomena. To overcome this problem, we used
transgenic mice harboring lox-P modified alleles of either the
vesicular glutamate transporter 2 (VGLUT2, encoded by Vglut2)
or vesicular GABA transporter (VGAT, encoded by Vgat) genes.
By stereotaxically injecting an adeno-associated virus (AAV) vector
containing the gene for Cre recombinase (AAV-Cre) into the SLD-
cLDT or LPT of Vglut2
flox/flox and Vgat
flox/flox mice, we selectively
and focally eliminated glutamate or GABA/glycine neurotrans-
mission, respectively, in these regions.
Results
Experiment 1: Delineating the neuroanatomical SLD and
cLDT in the mouse
As described above, previous work has suggested a critical role
for the SLD in the regulation of REM sleep and motor atonia.
Because, however, none of this previous work was performed in
the mouse, the first necessary step in the present study was to
delineate the neuroanatomic locus of the SLD in the mouse.
Following the injection of the retrograde tracer Fluoro-Gold (FG)
into the mouse ventral spinal horn (see methods), a population of
retrogradely labeled FG-positive neurons was identified in the
mesopontine tegmentum, just ventral to the region corresponding
to the mouse cLDT (Figure 1a). The locations of SLD and cLDT
are therefore similar to those in the rat [5,12] and this FG-labeled
population formed the basis of SLD coordinates for AAV-Cre or
AAV-GFP injections in the remaining experiments (Figure 1a).
Experiment 2: Determining the role of cLDT-SLD
glutamate in REM sleep regulation
Studies employing cell-body specific lesions in rats have
suggested a critical role for the cLDT-SLD and the SLD alone
in the control of REM sleep time and REM motor atonia,
respectively [5]. We have further hypothesized that glutamate
release from SLD neurons, in particular, is critical for motor
atonia during REM sleep. Because, glutamate and GABA (and
possibly other neurotransmitters and peptidergic systems) are
intermingled in the cLDT-SLD (Figure 1b,c), it has been difficult
to characterize the in vivo role of this fast neurotransmitter in
Figure 1. Distribution of VGLUT2-, VGAT- and Cre-positive neurons in the pontine tegmentum. (a) Retrograde-labeled neurons from the
spinal cord mark the mouse SLD. VGLUT2-positive neurons labeled by green fluorescent protein (GFP) are seen primarily in the cLDT-SLD,
precoeruleus (PC) and parabrachial nuclei (PB) (b), whereas VGAT-positive neurons (also a GFP proxy) are seen primarily in the cLDT and dorsal
tegmental nucleus (DTg) but not in the PB-PC (c). VGAT is also highly expressed in the vlPAG-LPT (d). Typical Cre labeled patterns after the AAV-Cre
injections targeting the cLDT-SLD are shown in (e) for VGLUT2 deletion and (f–g) for VGAT deletion. The AAV-cre filled areas from each VGLUT2 and
VGAT deletion cases are outlined in (h).
doi:10.1371/journal.pone.0024998.g001
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Experiment 2 was thus performed using mice (n=6) with loxP sites
flanking exon-2 of the Vglut2 gene (Vglut2
flox/flox). To selectively
eliminate glutamate neurotransmission in SLD neurons, we
injected AAV-Cre into the cLDT-SLD of the Vglut2
flox/flox mice.
As indicated above, when exposed to Cre recombinase, the second
exon is deleted, and the gene is no longer capable of expressing
functional protein and hence presynaptic release of glutamate
from cLDT-SLD neurons was disrupted in vivo [13]. As vector-
injection controls, we also injected AAV-GFP into the cLDT-SLD
of six Vglut2
flox/flox mice (Figure 1e and Figure 2).
Verification of VGLUT2 deletion in the cLDT-SLD is shown
in Figure 2. Of the six mice with AAV-Cre injections, five mice
showed Cre covering the cLDT and SLD bilaterally (Figure 1h).
One mouse had Cre labeling in the cLDT bilaterally but the SLD
was not filled. In all five mice showing bilateral Cre in the cLDT-
SLD, but not in AAV-GFP injected control mice or in the mouse
with Cre labeling restricted to the cLDT, we observed a dramatic
loss of motor atonia during REM sleep. Continuous motor atonia
during REM sleep was never observed in mice with bilateral Cre
in the cLDT-SLD, although atonia was occasionally present
during the first 1–3 s after REM sleep onset. Instead, we observed
overt motor behaviors during REM sleep in the AAV-Cre
injected Vglut2
flox/flox mice and these behaviors included both
simple movements (e.g., whole body twitches, jerking and
jumping; see supplementary Video S1) and, occasionally, more
complex motor behaviors, such as locomotion. Although we did
not measure the EMG of the limb muscles, the time-locked video
capture clearly revealed the occurrence and pattern(s) of limb
movements during REM sleep. Of note, and as shown in both
Figure 3b and supplementary Video S1, the limb movements and
motor behaviors observed in the AAV-Cre injected Vglut2
flox/flox
mice during putative REM sleep without atonia were distinct
from movements seen during wakefulness. In fact, the aberrant
motor behaviors observed during REM sleep were very similar to
those we have previously seen in rats with cell-body specific
lesions of the SLD and, also, resembled fundamental features of
human RBD. In summary, these observations strongly suggest
that glutamatergic neurons of the cLDT-SLD mediate REM
sleep motor atonia.
In addition to the absence of REM sleep motor atonia described
above, we also observed a significant reduction in total REM sleep
time in the AAV-Cre injected Vglut2
flox/flox mice. Total (24 h) REM
sleep time was decreased by nearly 40% in the AAV-Cre injected
mice as compared to AAV-GFP injected mice (4.7960.76% vs.
7.7560.54%, p,0.05). The decrease in REM sleep time was most
pronounced during the dark period (7 pm to 7am). In contrast to
REM sleep time, neither the total amount of wakefulness nor
NREM sleep was significantly altered in the AAV-Cre injected
Vglut2
flox/flox mice as compared with the AAV-GFP injected control
mice. These findings therefore suggest that glutamatergic cLDT-
SLD neurons might also play an important role in regulating
REM sleep amounts (Figure 4).
Another interesting feature of the REM sleep state observed in
the AAV-Cre injected mice was the severe fragmentation of REM
sleep. REM sleep frequency, which we defined operationally as the
number of REM episodes per 24 hours, was significantly increased
by ca. 75% (162.3622.6 versus 92.768.4 in the control group,
p,0.01). A highly significant increase in frequency was also
observed for NREM sleep (increase by 57%, 422.4635.8 versus
269.8626.1, p,0.01) and wakefulness (increase by 55%,
411.0634.7 versus 265.2626.6, p,0.01). The fragmentation of
the sleep cycle was further reflected by a highly significant
reduction in epoch duration during NREM (reduction by 34%)
and REM (reduction by 65%). In summary, fragmentation of the
sleep-wake cycle was most pronounced during the time that REM
sleep was high, and REM sleep was more severely affected than
NREM and wakefulness (Table 1, Figure 5).
Figure 2. Verification of VGAT and VGLUT2 mRNA knockout in the cLDT-SLD. The white dots of ‘‘c’’ and ‘‘d’’ label VGLUT2 mRNA and VGAT
mRNA in the cLDT-SLD respectively. The AAV-Cre injections in the cLDT-SLD region in a Vglut2
flox/flox mouse (a) eliminate VGLUT2 mRNA (c) the
glutamatergic PB that is not transfectionby AAV-Cre retains VGLUT2 mRNA. Similarly, AAV-Cre in the cLDT-SLD in a Vgat
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in the REM-off and REM-on areas in REM sleep regulation
We have previously hypothesized that GABAergic neurons in
the vlPAG-LPT may inhibit REM sleep via inhibition of REM-on
neurons in the cLDT-SLD. Our model also predicts an important
role for cLDT-SLD GABA in the regulation of REM sleep. For
reasons similar to that for glutamate, however, it has proven
difficult to characterize the in vivo role of GABA in regulating
REM sleep phenomena. To approach this problem, we selectively
disrupted GABAergic neurotransmission in the vlPAG-LPT using
the same experimental approach as described in Experiment 2,
but using the Vgat
flox/flox instead of the Vglut2
flox/flox mouse model.
Similar in design to experiment 2, we selectively eliminated GABA
neurotransmission in vlPAG-LPT or cLDT-SLD neurons by
injecting AAV-Cre into the vlPAG-LPT or cLDT - SLD of the
Vgat
flox/flox mice (Figure 1h, Figure 2). As vector-injection controls,
we also injected AAV-GFP into the vlPAG-LPT or cLDT-SLD of
Vgat
flox/flox mice (n=5). Our results showed that the VGAT
deletion in the cLDT-SLD or vlPAG-LPT did not result in any
significant changes in REM atonia, REM sleep amounts or REM
sleep architecture as compared with controls (Table 1).
Experiment 3: Ascending projections of REM-on
glutamatergic neurons
Given the above findings, we next sought to determine the potential
pathways through which glutamatergic cLDT-SLD neurons might
Figure 3. Normal sleep-wake and RBD like behavior episodes. Normal Wake, NREM and REM sleep EEG/EMG segments are shown in panel a.
In panel b, a mouse with conditional VGLUT2 knockout in the cLDT-SLD exhibits normal NREM sleep and normal transition into REM sleep.
Physiological atonia during REM sleep was observed only for a brief period which was followed by abnormally high muscle tone with kicking, jerking
and running during REM episode. Three images within less than two seconds are captured marked by a, a’ and a’’. The tail, posture and animal
positions indicate abrupt movement at the end of REM sleep. The entire REM episode lasts about 25 seconds. Notice that the figure shows only the
end of REM sleep because animals with RBD show the most dramatic and phasic locomotion (very different from normal waking) at this moment that
can be easily visualized by the pictures. The jerking and kicking during REM sleep that are never seen during wakefulness and NREM sleep are hard to
visualize by images; however, the supplementary video captures these behaviors very well. Power spectrum of wake, NREM, REM sleep in VGLUT2
knockout is easily distinguishable (c), and power spectrum of REM sleep between control and VGLUT knockout is virtually identical (d). The calibration
bar is 200 mV.
doi:10.1371/journal.pone.0024998.g003
REM Sleep Circuitry
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structuresinvolved in regulating the cortical featuresof REMsleep i.e.,
EEG desynchronization, we identified three candidate sites for
injection of CTb: the basal forebrain, intralaminar thalamus and
parabrachial nucleus (PB). We excluded the lateral hypothalamus as a
candidate injection site because it receives only sparse afferent inputs
from the cLDT/SLD region [14]. CTb was injected into one of each
of these three sites in Vglut2-GFP mice (provided by Vong, L and
Lowell BB, see methods). Glutamatergic projection neurons of the
cLDT-SLD were then identified by double immunolabeling for CTb
and GFP (n=4 per site).
Of the Vglut2-GFP mice receiving CTb injections only those with
injections into the PB produced double-labeled cells in the cLDT-SLD
(about 40% of CTb neurons were GFP+ and hence glutamatergic).
This finding indicates that the PB receives glutamatergic inputs from
the cLDT-SLD (Figure 6), whereas the basal forebrain and thalamus
do not. The tracer data further suggests a potentially important role
for the PB as an ascending ‘‘relay’’ for generating the cortical features
of REM sleep. In contrast, we found no evidence that cLDT-SLD
glutamatergic neurons project to the cortex via the thalamus or basal
forebrain (supplementary Figures S1 and S2).
Experiment 4. Spinal inhibitory interneurons mediate
atonia
To determine whether inhibitory (GABA/glycine) interneurons
in the spinal cord play a role in atonia, we placed bilateral
injections of AAV-Cre (100 nl) into the C3–C4 ventral horn
interneuron layer VII of Vgat
flox/flox mice (n=7). These mice were
also outfitted with EEG/EMG recording leads. We found that
mice with deletion of VGAT in the ventral horn region (n=4) but
not in the dorsal horn region (n=3) at C3–C4 level exhibited
twitching and jerking movements mostly in the upper and
occasionally lower body extremities (including tail movements)
during REM sleep (Figure 7, supplementary Video S2). We did
not however observe any form of locomotion in the mice with loss
of VGAT in the ventral horn during REM sleep. We did not
observe detectable changes in motor behaviors during wakefulness
and NREM sleep.
Discussion
We have previously reported that cell-body specific lesions of
the SLD (including unilateral lesions), but not the cLDT, in rats
produced a loss of motor atonia during REM sleep. In addition,
retrograde tracing studies have revealed that the SLD, but not
cLDT, sends direct projections to both the ventromedial medulla
(VMM) and ventral horn interneuron layers of the spinal cord,
both of which are CNS regions implicated in REM atonia. Cell-
body specific lesions of the entire cLDT-SLD, but not the cLDT
or SLD alone, in rats produced a profound reduction in REM
sleep (ca. 60%) and REM sleep fragmentation [5]. The present
study provides the first in vivo evidence that glutamatergic neurons
Figure 4. Circadian and day-night changes of wake, NREM sleep and REM sleep. Theleft panelshows anhourlypercentage sleep-waketime
over 24 hrs. The right panel shows the percentage of wake, NREM sleep, REM sleep time during light, dark and light+dark periods (24 hrs). REM sleep
reduction in the VGLUT2 knockout group appears evenly across 24 hrs, although the magnitude is higher during the night. * p,0.05, ** p,0.01.
doi:10.1371/journal.pone.0024998.g004
REM Sleep Circuitry
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that these neurons together with glycinergic/GABAergic inter-
neurons of the spinal ventral horn (and premotor neurons in the
VMM) mediate REM atonia, whereas a presumably separate
population of glutamatergic neurons in the cLDT and SLD are
important for REM sleep consolidation. We also observed an
unexpected absence of REM sleep changes following the in vivo
disruption of GABA neurotransmission in the cLDT-SLD and the
vlPAG-LPT regions.
Due to the relatively small size of the mouse SLD and cLDT, we
did not attempt to distinguish between the effects of Vglut2
deletion in the SLD versus the cLDT. However, in one mouse loss
of Vglut2 was restricted to the cLDT and although this mouse
demonstrated a slight reduction in REM sleep (5.8%/24 hrs),
Table 1. The effects of VGLUT2 and VGAT knockout on average bout duration (sec) and frequency of wake, NREM sleep and REM
















flox/flox Control 191.2622.4 265.2626.6 139.4610.7 269.8626.1 72.864.3 92.768.4
AAV-Cre into
cLDT-SLD
137.5614.0 411634.7** 92.6610.3** 422.4635.8** 25.463.5*** 162.3622.6*
Vgat
flox/flox Control 120.768.1 343.6620.4 116.567.7 353.4622.7 60.763.1 116.066.8
AAV-Cre into
cLDT-SLD
121.667.5 355.9625.7 113.9615.7 330.6642.1 55.465.7 113.4612.4
AAV-Cre into
vlPAG-LPT





Figure 5. Stage changes of VGLUT2 knockout in the cLDT-SLD. Compared to a representative control animal (top), the mouse with VGLUT2
knockout (bottom) in the cLDT-SLD exhibits profound fragmentation in REM sleep, NREM sleep and wakefulness, and this is most evident during the
light (rest) period (7:00–19:00).
doi:10.1371/journal.pone.0024998.g005
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results from previous rat lesion work [5], the present study suggests
that SLD glutamatergic neurons projecting to the VMM and/or
the spinal cord are involved in the regulation of REM sleep atonia,
whereas a separate population of glutamatergic neurons [12],
which are distributed over both the SLD and cLDT, are involved
in the regulation of REM sleep timing and consolidation. We also
demonstrated that glutamatergic cLDT-SLD neurons project
directly to the parabrachial nucleus (PB), but not to the thalamus
or basal forebrain, suggesting a possibly ‘‘relay’’ role for the PB in
the regulation of the cortical and hippocampal EEG during REM
sleep. For example, it has been shown previously that the PB sends
excitatory glutamatergic projections to both basal forebrain
corticopetal cholinergic and GABAergic neurons, which in turn
regulate cortical and hippocampal activity [15]. Interestingly
however we found that Vglut2 deletion in the cLDT-SLD did not
alter the spectral characteristics of the REM sleep EEG, indicating
that the glutamatergic cLDT-SLD neurons may not be the only
neuronal population important for cortical activation during REM
sleep.
The present study also suggests that GABA release from the
vlPAG-LPT and cLDT-SLD is not critically involved in REM
sleep control. This finding was unexpected on the basis of the
results from several previous studies. For example, previous Fos
studies have indicated that both GABAergic and glutamatergic
neurons in the cLDT and SLD are REM-active [4,5,16]. It is also
the case that cell-body lesions and injections of the GABA agonist
muscimol into the vlPAG-LPT in rat [7], cat [9] and guinea pig
increase REM sleep [10], and injections of GABA antagonists in
the SLD trigger REM sleep in rats [4]. Finally, we had previously
proposed a model in which mutual inhibitory projections from
GABAergic neurons in the SLD and vlPAG-LPT may form the
Figure 6. cLDT-SLD glutamatergic neurons project to the parabrachial nucleus. The retrograde tracer CTb injected into the parabrachial
nucleus (mostly ventral LPB and MPB) bordered by a white line of VGLUT2-GFP mice (a) labels many neurons that are also glutamatergic in the cLDT-
SLD (b, c). The box in (b) is enlarged in (c), where arrows indicate double-labeled neurons and arrowheads indicate single VGLUT2 labeled neurons.
doi:10.1371/journal.pone.0024998.g006
Figure 7. VGAT knockout in the spinal cord produces REM without atonia. ‘‘a’’ shows the absence of atonia (arrow points at twitches)
during a REM sleep segment (high theta EEG) in a mouse with Vgat knockout in the C3–C4 ventral horn region (also see supplementary Video S2). ‘‘b’’
shows the Cre-labeled neurons (right side) in the ventral horn and loss of VGAT mRNA in the corresponding region (left). The calibration bar is 200 mV.
doi:10.1371/journal.pone.0024998.g007
REM Sleep Circuitry
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however that genetic disruption of GABA/glycine neurotransmis-
sion from these structures does not produce significant changes in
REM sleep. While this finding is difficult to explain, we cannot
exclude the possibilities that other, and as yet unrevealed, vesicular
GABA transporters or co-localized inhibitory neurotransmitters in
the GABAergic cLDT-SLD and vlPAG-LPT neurons may play a
role in REM sleep control. It is also possible that GABAergic
neurons in the cLDT-SLD might work synergistically with REM-
controlling glutamatergic neurons (i.e., those identified in the
present study) because the reduction in REM sleep observed
following deletion of Vglut2 in the cLDT-SLD was smaller in
magnitude than that produced by cell-body specific lesions in the
same region in the rat.
As the cLDT also contains a small number of cholinergic
neurons, the possibility exists that cholinergic neurons in the cLDT
are also involved in REM sleep control. This idea has been
previously proposed [17]. However, cell-body lesions of the cLDT
alone do not affect REM sleep [5] and deletion of Vglut2 in the
cLDT-SLD recapitulates the reduction in REM sleep seen
following cell-body specific lesions of the same region. In addition,
LDT cholinergic neurons do not contain glutamate or GABA
[18]. Taken together, the available data support that the cLDT-
SLD glutamatergic neurons regulate REM sleep.
As would be expected, REM sleep fragmentation resulted in
overall changes in sleep-wake consolidation. We were however
surprised at the magnitude of fragmentation in NREM sleep and
wakefulness following Vglut2 deletion from cLDT-SLD. Despite
the fragmentation, we did not observe a change in total NREM
sleep and wake time. Similar patterns of fragmentation, albeit to a
lesser degree, have also been reported in other animal models of
disrupted sleep, including rats with lesions of the ventrolateral
preoptic nucleus or mice with genetic disruption of orexin and/or
histamine signaling [19,20,21].
Vglut2 deletion in the cLDT-SLD resulted in REM fragmenta-
tion characterized by reductions in REM sleep epoch duration
coupled with an increase in the number of REM episodes (see
Figure 5 and Table 1). These results indicate that glutamatergic
neuronsinthe cLDT-SLDregionarecriticalfor the maintenanceof
REMsleep.Importantly,however,whileneuronsofthecLDT-SLD
are clearly critical for generating and maintaining REM sleep, the
regulation of REM sleep likely requires the participation of other
brainstem structures, such as circuitry in the ventromedial medulla
[12].Forexample,ithasbeen shownthatpretrigeminaltransections
in the cat virtually eliminated REM sleep [22] and that transections
caudal to the cLDT-SLD blocked REM induction by carbachol
injection into the pons in cats [23]. These findings strongly suggest
that cLDT-SLD neurons and REM-active medullary circuits work
together to generate and maintain REM sleep.
Chase and colleagues first showed that glycine mediates motor
inhibition during REM sleep, however the source of this inhibition
has been long debated. We have previously hypothesized that
spinal cord inhibitory premotor neurons are critical for REM
atonia [5,12]. In the present study we found that deletion of
GABA/glycine release from spinal ventral horn interneurons
resulted in deficits in REM atonia in mice. As GABA/glycine
deletion was confined to C3–C4 in our experiments, it was not
surprising that the magnitude of disinhibition of the motor
behaviors was much less than that caused by SLD glutamate
deletion. Ultimately, it will be necessary to produce deletion of
spinal glycine/GABA transmission along the entire spinal axis to
demonstrate that inhibitory premotor neurons in the spinal cord
are responsible for REM sleep atonia. This was not possible in the
present study.
We have previously proposed that glutamate in the VMM
might be critical for suppressing phasic muscle activity during
REM sleep as disruption of glutamate transmission in the ventral
medulla produces more prominent phasic activity of EMG than
disruption of GABA/glycine transmission. Importantly, however,
neither glutamate nor GABA/glycine deletion from the VMM nor
VMM lesions recapitulated the complete loss of muscle atonia or
the overt motor behaviors during REM sleep as seen in the SLD
Vlgut2 knockout [12]. Thus, glutamatergic neurons in the SLD
may act on all three populations (glutamatergic and GABA/
glycinergic neurons in the VMM and GABA/glycinergic inter-
neurons in the spinal cord) to bring about muscle atonia during
REM sleep. In addition, simultaneous withdrawal of monoamin-
ergic and orexinergic neurotransmission may also be required for
generation and maintenance of muscle atonia as previously
suggested [12,24].
The loss of REM atonia observed following genetic deletion of
Vglut2 from the SLD was highly reminiscent of human RBD.
RBD is a parasomnia typically manifested as ‘dream enactment’
behavior’ and is thought to represent an early pathophysiologic
manifestation of evolving Parkinson’s disease (PD) and other
synucleinopathies, e.g., Lewy body dementia (LBD), multiple
system atrophy (MSA) and pure autonomic failure [25,26,27].
Mathis and colleagues recently reported on a case of RBD that
developed following a rare encephalitis-induced lesion that was
restricted to the dorsal pontine tegmentum and presumably
involved the subcoeruleus region bilaterally. Also interesting is the
recent report of human RBD development following a stroke in
the right SLD region [28]. Finally, a recent imaging study has
reported tissue abnormalities in the pontine tegmentum in an
idiopathic RBD case [29].
Methods
Animals
The male mice were housed in the Center for Life Science
animal facility and the care of the animals in this study met
National Institutes of Health standards, as set forth in the Guide for
the Care and Use of Laboratory Animals. All protocols were approved by
the Beth Israel Deaconess Medical Center Institutional Animal
Care and Use Committee (Animal Welfare Assurance #A3153-
01). The animals were individually housed in standard plastic
mouse cages with ad libitum access to food (Lab Diet) and water.
The cages were housed inside isolation chambers, which provided
ventilation, computer-controlled lighting (12:12 light-dark cycle,
lights on at 07:00; 200 lux), an ambient temperature of 2261uC,
and visual isolation.
Conditional Knock-out Mice. The generation and
characterization of the Vgat
flox/flox and Vglut2
flox/flox mice were
described in detail previously [13,30].
VGLUT2-GFP and VGAT-GFP mice. These mice are
generated and provided by Drs. Vong and Lowell. To generate
the VGLUT2-GFP and VGAT-GFP mice used in Experiment 4,
Vglut2-ires-cre and Vgat-ires-cre mice were bred to lox-GFP
reporter mice (cite paper). As expected, Cre activity as measured by
GFP immunohistochemistry was observed only in glutamatergic
and GABAergic neurons, respectively.
Tracer injections
Tracer injections into the brain and spinal cord have been
described in detail previously [5,12,17].
Microinjection and implantation of EEG/EMG leads. To
selectively eliminate glutamate and GABA/glycine neurotransmission,
we injected 100 nl of an adeno-associated viral (AAV) vector
REM Sleep Circuitry
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AP=25.3 mm, ML=60.7 mm, DV=23.4 mm) or vlPAG-LPT
(coordinates: AP=24.2 mm, ML=60.8 mm, DV=23.0 mm) of
the Vglut2
flox/flox and Vgat
flox/flox mice (25–35 g). AAV-GFP was injected
into different Vglut2
flox/flox or Vgat
flox/flox mice to serve as controls. All
injections were performed using the same compressed air delivery
system previously described [21]. Immediately following injections of
either AAV-Cre (Serotype 10, 90 nl) or AAV-GFP (Serotype 10,
90 nl), four EEG electrodes (0.10, Pinnacle Technology Inc.) and two
nuchal EMG electrodes (Plastics One), previously soldered to a 6-pin
connector (Pinnacle Technology Inc.), were implanted (AP+1.0 mm/
RL 61a n dA P22.0 mm/RL 61.0 mm) and insulated with dental
cement [31].
Similarly, for anatomical tracing experiments, a retrograde tracer,
cholera toxin subunit b (CTb) was injected into the basal forebrain
(AP=20.1 mm, ML=61.5 mm, DV=24.2 mm), intralaminar
thalamus (AP=21.0 mm, ML=60.5 mm, DV=23.0 mm) or
parabrachial nucleus (AP=25.3 mm, ML=61.3 mm, DV=
22.3 mm) in VGLUT2-GFP mice. These animals were not
implanted with EEG/EMG electrodes.
EEG/EMG recording and sleep-wake analysis. Three
weeks after surgery, the mice were connected via flexible recording
cables, containing a preamplifier, to a commutator, which in turn
was connected to an amplifier (Pinnacle Technology Inc.) and a
computer. The mice were habituated to the setting for three days.
Continuous recording of the EEG/EMG and time-lock video
(Sirenia Pinnacle Technology Inc.) began after the habituation
period and continued for 48 hours. Three behavioral states (Wake,
NREM and REM sleep) were visually identified and analyzed in
10-s epochs using SleepSign for Animal (Kissei, Japan) [12].
The percentage of time spent in wake, NREM sleep and REM
sleep, frequency and the average durations of each stage were
summarized for each group. Statistical differences in sleep-wake
time, episode number, and duration were assessed using a
Student’s two-tailed t-test, after a normal distribution was
confirmed for each group and a test for variance homoscedasticity
was performed. An a,0.05 was considered significant.
For the EEG power spectrum analysis, 4 hrs (7–11pm) of
spontaneous recordings were scored again in 10 s epochs. On the
basis of visual and spectral analysis, epochs containing artifacts
occurring during active wake (with large movements) or
immediately before or after other vigilance states were visually
identified and omitted from the spectral analysis. EEG power
spectra were computed for consecutive 10 s epochs within the
frequency range of 0.5–60 Hz using a fast Fourier transform
routine. The data were collapsed in 0.75 Hz bins. The power
densities obtained for each state were summed over the frequency
band of 0.5–60 Hz (total power). To standardize the data, each
frequency bin was expressed as a percentage relative to the total
power (e.g., bin power/total power) of the same epochs. To
analyze the EEG frequency bands, relative power bins were
summed in d 0.5–2.5 Hz, slow h 2.5–5.5 Hz, fast h 5.5–10, a 10–
20 Hz, b+c 20–60 Hz.
In situ hybridization and immunohistochemistry. Immu-
nohistochemical staining for Cre and GFP was performed as
previously described previously [12,31]. In situ hybridization for
labeling of Vglut2 mRNA or Vgat mRNA was also performed as
previously described and is also illustrated by Figure 2
[5,12,17,31,32].
Supporting Information
Video S1 RBD-like behavior after genetic disruption of
Vglut2 in the mouse SLD-cLDT. Almost every REM episode
following genetic disruption of glutamatergic transmission in the
cLDT-SLD [by injections of AAV-Cre in a Vglut2
flox/flox mouse]
was marked by an absence of atonia, and which ranged from
simple movements (e.g., whole body twitches, jerking and
jumping) to, occasionally, more complex motor behaviors (e.g.,
locomotion).
(MP4)
Video S2 REM sleep without atonia after conditional
knockout of Vgat in the spinal cord. Injection of AAV-Cre
into the C3–C4 interneuron level of a Vgat
flox/flox mouse resulted in
an absence of atonia during many REM episodes and this was
characterized by twitches, esp. in the cervical region and upper
body but also occasionally in the lower body (legs and tail).
(AVI)
Figure S1 cLDT-SLD glutamatergic (VGLUT2) neurons
do not project to the thalamus. Although CTb injected into
the intralaminar thalamus (a) retrogradely labels numerous large-
size neurons (red color) in the cLDT, most of these cells are likely
cholinergic (b), and CTb-labeled neurons in the cLDT-SLD rarely
contained VGLUT2 (green color) (b). Arrows indicate double-
labeled neurons.
(TIF)
Figure S2 cLDT-SLD glutamatergic (VGLUT2) neurons
do not project to the basal forebrain. CTb injected into the
basal forebrain (a) retrogradely labels many glutamatergic neurons
in the parabrachial nucleus (PB) but rarely glutamatergic neurons
in the cLDT-SLD. Arrow indicates a double-labeled neuron
(yellow color); lat PB: lateral parabrachial nucleus; med PB: medial
parabrachial nucleus; MDT: mediodorsal thalamus; scp: superior
cerebellar peduncle; ven: fourth ventricle.
(TIF)
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